Ephedra Sales Ban Gains Congressional Momentum Following Athlete’s Death
This article was originally published in The Tan Sheet
Reps. John Sweeney (R-N.Y.) and Greg Walden (R-Ore.) announced plans to challenge ephedra's safety and address restrictions on the sale of the controversial ingredient following the death of professional baseball player Steve Bechler
You may also be interested in...
Nutraquest President Robert Chinery is seeking to shift any future liability and damages found against him for the death of Baltimore Orioles pitcher Steve Bechler to the Orioles organization
Cytodyne's failure to adequately warn consumers about potential risks from taking ephedra-containing Xenadrine RFA-1 is the basis for a wrongful-death lawsuit filed by Orioles pitcher Steve Bechler's widow, Kiley Bechler, July 16
The House Energy & Commerce Committee launched an investigation into the safety of ephedra Feb. 28 by sending letters to FDA Commissioner Mark McClellan, MD/PhD, and Cytodyne Technologies President Robert Chinery